01

  • A.C. Matin dies at 83

    The microbiologist, on the faculty for nearly half a century, studied a wide range of topics, including antibiotic resistance, cancer, and bacteria as an agent for cleaning up toxic chemicals.

  • Wes Brown dies at 63

    Brown developed stem-cell therapies for patients who suffered infections after receiving blood or bone marrow transplants.

  • Register for RAISE Health symposium

    Register for the inaugural RAISE Health symposium, which will convene leaders in artificial intelligence for discussions on safe and responsible AI innovation.

  • Pump for kids’ failing hearts

    A new type of surgically implanted pump that can support a child’s failing heart has passed the first stage of human testing in a Stanford Medicine-led trial.

  • Cell-based therapy for solid tumors

    The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.

  • Stanford Medicine magazine on psychiatry

    The new issue of Stanford Medicine magazine reports on emerging research and innovative treatments to improve mental health.

  • Biochemist Lubert Stryer dies at 86

    Stryer made fundamental discoveries in fluorescence spectroscopy and vision, established structural biology at Stanford, and uplifted young scientists.

  • Shedding light on exercise’s effects

    A Stanford Medicine-led effort to learn more about exercise’s molecular effects paints the broadest picture yet of why, in the health arena, sweat is king.

  • Studying neurodevelopmental disorders

    Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

  • Chuck Chan dies at 48

    The Stanford Medicine researcher was known for his groundbreaking work and his generous spirit as a mentor and colleague.


2024 ISSUE 1

Psychiatry’s new frontiers